Results 221 to 230 of about 1,046,192 (353)
Emerging Trends in Vaccine Development Integrating Pharmaceutical Science with Public Health
Vausan Mafuts
openalex +2 more sources
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against nonsteroidal anti‐inflammatory drug (NSAID) use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal
Adam S. Mayer +5 more
wiley +1 more source
Alexey I. Slivkin (to the 80th anniversary of the birth)
On 15 June 2024, Alexey Ivanovich Slivkin, the head of the Department of Pharmaceutical Chemistry and Pharmaceutical Technology of the Faculty of Pharmacy, Voronezh State University, Professor, Doctor of Pharmaceutical Sciences, Honored Worker of Higher ...
article Editorial
doaj
Impact of Positive Lifestyle Behaviors on Direct Health Care Cost Savings for Low Back Pain
Objective This study aimed to investigate the relationship between a previously purpose‐developed lifestyle behavior scale and health care cost savings related to low back pain (LBP). Methods This longitudinal study used data from the Australian Twin Back (AUTBACK) study. LBP and lifestyle behavior measures were collected at baseline. Physical activity
Ye Tian +8 more
wiley +1 more source
Publication Rates for Pharmaceutical Sciences Faculty Members at Nonresearch-Intensive US Schools of Pharmacy. [PDF]
Bloom TJ, Schlesselman L.
europepmc +1 more source
Modelling of drying processes of pharmaceutical granules. Pharmaceutical Sciences for the Future of Medicines [PDF]
De Beer, T. +6 more
core
Using Design Science Research to develop Online Enhanced Pharmaceutical Care Services
Luís Velez Lapão +5 more
openalex +2 more sources
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records. Methods We searched Medline, Embase, and Cochrane Central Register for Controlled Trials databases and included studies that validated case definitions against a ...
Constanza Saka‐Herrán +10 more
wiley +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
UBC opens new Pharmaceutical Sciences Building. [PDF]
Lynas K.
europepmc +1 more source

